Life Science Big News Roundup: BriaCell Closes Non-Brokered Private Placement; Avricore Health Appoints CEO, President and Advisors
In case you missed it, here is this week’s life science big news roundup.
Bion Announces Key Legislation Calendared in Pennsylvania House Committee
Bion Environmental Technologies, Inc. announced that Pennsylvania Senate Bill 575 has been calendared in the PA House State Government Committee.
Naturally Splendid Positions for Evolving CBD Market as New Regulations Commence
Naturally Splendid is pleased to provide insight in regard to strategic positioning in the evolving cannabinoid extract, edibles markets.
BriaCell Announces Closing of Non-Brokered Private Placement of $568,444
BriaCell Therapeutics Corp. announces that it has closed its previously-announced non-brokered private placement.
Life Science Big News Roundup: BriaCell Doses First Patient in Phase I/IIa Study; PreveCeutical Receives AU$616,802 R&D Tax Incentive Cash Refund; Lexaria Provides Update on R&D Program with Altria
In case you missed it, here is this week’s life science big news roundup.
Auris Medical Releases Results from MAP US2 Open-Label Extension Study
The company announced results from its Phase 1b trial with AM-201 in antipsychotic-induced weight gain and somnolence.
RedHill Biopharma Releases Positive Results from MAP US Phase 3 Study
The company announced positive results from its MAP US Phase 3 Study and MAP US2 Open-Label Extension Study